Alexey Manikhas

Author PubWeight™ 19.80^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.	Lancet	2010	5.79
2	Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer.	J Clin Oncol	2009	4.69
3	Phase II randomized study of neoadjuvant everolimus plus letrozole compared with placebo plus letrozole in patients with estrogen receptor-positive breast cancer.	J Clin Oncol	2009	4.12
4	Randomized phase III trial of ixabepilone plus capecitabine versus capecitabine in patients with metastatic breast cancer previously treated with an anthracycline and a taxane.	J Clin Oncol	2010	1.59
5	A single-arm phase II trial of first-line paclitaxel in combination with lapatinib in HER2-overexpressing metastatic breast cancer.	Oncology	2010	0.90
6	A randomized phase II study of lapatinib + pazopanib versus lapatinib in patients with HER2+ inflammatory breast cancer.	Breast Cancer Res Treat	2012	0.88
7	A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancer.	Breast Cancer Res Treat	2007	0.82
8	Maintenance of clinical efficacy after dose reduction of ixabepilone plus capecitabine in patients with anthracycline- and taxane-resistant metastatic breast cancer: a retrospective analysis of pooled data from 2 phase III randomized clinical trials.	Clin Breast Cancer	2012	0.78
9	A phase II multicenter study of two different dosages of pemetrexed given in combination with cyclophosphamide as first-line treatment in patients with locally advanced or metastatic breast cancer.	Cancer Invest	2012	0.77